149 related articles for article (PubMed ID: 1520538)
1. Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction.
Aoki-Sei S; Yarchoan R; Kageyama S; Hoekzema DT; Pluda JM; Wyvill KM; Broder S; Mitsuya H
AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1263-70. PubMed ID: 1520538
[TBL] [Abstract][Full Text] [Related]
2. Monitoring the activity of antiviral therapy for HIV infection using a polymerase chain reaction method coupled with reverse transcription.
Kojima E; Shirasaka T; Anderson B; Chokekijchai S; Sei S; Yarchoan R; Mitsuya H
AIDS; 1993 Nov; 7 Suppl 2():S101-5. PubMed ID: 8161438
[TBL] [Abstract][Full Text] [Related]
3. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.
Piatak M; Saag MS; Yang LC; Clark SJ; Kappes JC; Luk KC; Hahn BH; Shaw GM; Lifson JD
AIDS; 1993 Nov; 7 Suppl 2():S65-71. PubMed ID: 7909227
[TBL] [Abstract][Full Text] [Related]
4. Amplification and detection of a single molecule of human immunodeficiency virus RNA.
Nakamura S; Katamine S; Yamamoto T; Foung SK; Kurata T; Hirabayashi Y; Shimada K; Hino S; Miyamoto T
Virus Genes; 1993 Dec; 7(4):325-38. PubMed ID: 8122393
[TBL] [Abstract][Full Text] [Related]
5. Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.
Yerly S; Kaiser L; Baumberger C; Hirschel B; Perrin LH
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):358-64. PubMed ID: 7882100
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma.
Cao Y; Ho DD; Todd J; Kokka R; Urdea M; Lifson JD; Piatak M; Chen S; Hahn BH; Saag MS
AIDS Res Hum Retroviruses; 1995 Mar; 11(3):353-61. PubMed ID: 7786581
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of unintegrated HIV-1 DNA in asymptomatic patients in the presence or absence of antiretroviral therapy.
Bush CE; Donovan RM; Smereck SM; Strang D; Markowitz N; Saravolatz LD
AIDS Res Hum Retroviruses; 1993 Feb; 9(2):183-7. PubMed ID: 8096146
[TBL] [Abstract][Full Text] [Related]
8. Plasma viraemia as a marker of viral replication in HIV-infected individuals.
Escaich S; Ritter J; Rougier P; Lepot D; Lamelin JP; Sepetjan M; Trepo C
AIDS; 1991 Oct; 5(10):1189-94. PubMed ID: 1723881
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 plasma viraemia quantification: a non-culture measurement needed for therapeutic trials.
Semple MG; Kaye S; Loveday C; Tedder RS
J Virol Methods; 1993 Feb; 41(2):167-79. PubMed ID: 8496293
[TBL] [Abstract][Full Text] [Related]
10. Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA, and p24 antigen from samples collected in VACUTAINER CPT and standard VACUTAINER tubes.
Mole L; Margolis D; Carroll R; Todd J; Holodniy M
J Clin Microbiol; 1994 Sep; 32(9):2212-5. PubMed ID: 7814549
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of HIV-1 proviral DNA in peripheral blood mononuclear cells from patients with AIDS or ARC: decrease of proviral DNA content following treatment with 2',3'-dideoxyinosine (ddI).
Aoki S; Yarchoan R; Thomas RV; Pluda JM; Marczyk K; Broder S; Mitsuya H
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1331-9. PubMed ID: 2127682
[TBL] [Abstract][Full Text] [Related]
12. Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS.
Jurriaans S; Weverling GJ; Goudsmit J; Boogaard J; Brok M; Van Strijp D; Lange J; Koot M; Van Gemen B
AIDS Res Hum Retroviruses; 1995 Apr; 11(4):473-9. PubMed ID: 7632462
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of human immunodeficiency virus (HIV) with respect to disease stage and zidovudine (AZT) therapy.
Ved Brat SS; Shepherd LP; Boulberhane A; Pierce PF; Hellman KB
AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1271-81. PubMed ID: 1520539
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of three different commercial procedures for quantifying human immunodeficiency virus type-1 RNA levels.
Aschbacher R; Monari P; Lolli S; Donzelli C; Colangeli V; Vignoli M; Ramazzotti E; Furlini G; Re MC
New Microbiol; 1999 Jan; 22(1):1-9. PubMed ID: 10190111
[TBL] [Abstract][Full Text] [Related]
15. [HIV-1 proviral DNA sequences in the saliva of patients with HIV infection].
Piazza M; Chirianni A; Liuzzi G; Tullio Cataldo P; Santoro G; Barsanti L; Batoni G; Ceccherini Nelli L
Boll Soc Ital Biol Sper; 1992 Jul; 68(7):475-81. PubMed ID: 1362355
[TBL] [Abstract][Full Text] [Related]
16. Frequent detection of HIV-1-specific mRNAs in infected individuals suggests ongoing active viral expression in all stages of disease.
Schnittman SM; Greenhouse JJ; Lane HC; Pierce PF; Fauci AS
AIDS Res Hum Retroviruses; 1991 Apr; 7(4):361-7. PubMed ID: 1676896
[TBL] [Abstract][Full Text] [Related]
17. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy.
Semple M; Loveday C; Weller I; Tedder R
J Med Virol; 1991 Sep; 35(1):38-45. PubMed ID: 1940882
[TBL] [Abstract][Full Text] [Related]
18. Quantification of low levels of human immunodeficiency virus (HIV) type 1 RNA in P24 antigen-negative, asymptomatic, HIV-positive patients by PCR.
Muñoz-Fernández MA; Navarro J; Montes MG; Cosín J; Zabay JM; Fernández-Cruz E
J Clin Microbiol; 1996 Feb; 34(2):404-8. PubMed ID: 8789024
[TBL] [Abstract][Full Text] [Related]
19. The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.
Elion R; Kaul S; Knupp C; Adler M; Cross AP; Dunkle LM; Kelleher T
Clin Ther; 1999 Nov; 21(11):1853-63. PubMed ID: 10890257
[TBL] [Abstract][Full Text] [Related]
20. Measuring viral load in the clinical setting.
Harrigan R
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S34-40. PubMed ID: 8595506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
